FASN and metabolic dysfunction-associated steatotic liver disease: Supplementing Astragalus polysaccharide in mice with non-alcoholic fatty liver disease (NAFLD) specifically increased the abundance of Desulfovibrio, increased acetic acid-dominant SCFAs, and suppressed the expression of the key protein for hepatic lipid synthesis, fatty acid synthase (FASN)/CD36.